摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氨基-4-溴苯并噻唑 | 20358-02-5

中文名称
2-氨基-4-溴苯并噻唑
中文别名
4-溴-2-氨基苯并噻唑
英文名称
4-bromobenzo[d]thiazol-2-amine
英文别名
2-amino-4-bromobenzothiazole;4-bromo-1,3-benzothiazol-2-amine;2-Amino-4-brom-benzthiazol
2-氨基-4-溴苯并噻唑化学式
CAS
20358-02-5
化学式
C7H5BrN2S
mdl
MFCD04971840
分子量
229.1
InChiKey
FVMCARDEQKVVIS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    182-184 °C(Solv: ethanol (64-17-5))
  • 沸点:
    366.8±34.0 °C(Predicted)
  • 密度:
    1.836±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    67.2
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2934999090
  • 危险品运输编号:
    UN 2811
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    2-8°C

SDS

SDS:0bb5d39e8bcf429f380a70dd9da91e47
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Amino-4-bromobenzo[d]thiazole
Synonyms: 4-Bromobenzo[d]thiazol-2-amine

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-4-bromobenzo[d]thiazole
CAS number: 20358-02-5

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H5BrN2S
Molecular weight: 229.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide, sulfur oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-氨基-4-溴苯并噻唑(1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride氯[(三环己基膦)-2-(2-氨基联苯)]钯(II)potassium acetate 、 sodium carbonate 、 三乙胺三氟乙酸 作用下, 以 四氢呋喃1,4-二氧六环二氯甲烷 为溶剂, 反应 73.0h, 生成 N-(4-(4-(2-aminoethylsulfonyl)-3-sulfamoyl-2-(2H-tetrazol-5-yl)phenyl)benzo[d]thiazol-2-yl)acetamide
    参考文献:
    名称:
    [EN] METALLO-BETA-LACTAMASE INHIBITORS
    [FR] INHIBITEURS DE MÉTALLO-BÊTA-LACTAMASES
    摘要:
    本发明涉及一种属于金属β-内酰胺酶抑制剂的I式化合物,以及这种化合物的合成和将其与β-内酰胺类抗生素一起用于克服耐药性的用途。
    公开号:
    WO2016206101A1
  • 作为产物:
    描述:
    2-溴苯胺盐酸盐盐酸 作用下, 以 氯仿 为溶剂, 反应 4.5h, 生成 2-氨基-4-溴苯并噻唑
    参考文献:
    名称:
    合成的3-(1,3-苯并噻唑-2-基)2-苯基喹唑啉-4(3 H)-作为强效抗菌剂的QSAR建模
    摘要:
    目前的通讯引发了作为潜在抗菌剂的3-(1,3-苯并噻唑-2-基)2-苯基喹唑啉-4(3 H)-one的设计和合成。[( -一个数字取代的2-苯并噻唑氨基的,2-氨基-5- ë) -苯基二氮烯基]苯甲酸,和2-苯基-4- ħ恶嗪-4-酮合成为苯并[d] [1,3]前体基板。这些化合物以极高的收率合成,并且根据IR,1证实了结构1 H NMR,质量和元素分析数据。体外筛选了这些化合物对革兰氏阳性和革兰氏阴性细菌代表菌群的抗菌活性,并通过定量结构-活性关系(QSAR)建立了模型,并使用顺序回归程序确定了由于结构和取代作用而引起的活性贡献。抗菌测定数据表明,发现合成的化合物表现出深远的抗菌活性。
    DOI:
    10.1007/s00044-011-9626-0
点击查看最新优质反应信息

文献信息

  • METALLO-BETA-LACTAMASE INHIBITORS
    申请人:Merck Sharp & Dohme Corp.
    公开号:US20160333021A1
    公开(公告)日:2016-11-17
    The present invention relates to compounds of formula (I) that are metallo-β-lactamase inhibitors, the synthesis of such compounds, and the use of such compounds for use with β-lactam antibiotics for overcoming resistance.
    本发明涉及式(I)的化合物,这些化合物是金属β-内酰胺酶抑制剂,以及这些化合物的合成和与β-内酰胺类抗生素一起用于克服耐药性的用途。
  • [EN] NOVEL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS
    申请人:GLAXO GROUP LTD
    公开号:WO2012035055A1
    公开(公告)日:2012-03-22
    The invention is directed to certain novel compounds. Specifically, the invention directed to compounds of formula (I) and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular Itk activity.
    这项发明涉及某些新颖的化合物。具体地,该发明涉及公式(I)的化合物及其盐。该发明的化合物是激酶活性抑制剂,特别是Itk活性的抑制剂。
  • [EN] SUBSTITUTED BENZIMIDAZOLES, BENZOTHIAZOLES AND BENZOXAZOLES<br/>[FR] BENZIMIDAZOLES, BENZOTHIAZOLES ET BENZOXAZOLES SUBSTITUÉS
    申请人:GRUENENTHAL GMBH
    公开号:WO2010142402A1
    公开(公告)日:2010-12-16
    The present invention relates to substituted benzimidazoles, benzothiazoles and benzoxazoles, processes for their preparation, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.
    本发明涉及取代苯并咪唑、苯并噻唑和苯并噁唑,其制备方法,含有这些化合物的药物以及利用这些化合物制备药物的用途。
  • [EN] SMALL MOLECULE MODULATORS OF MHC-I<br/>[FR] MODULATEURS À PETITES MOLÉCULES DU CMH-1
    申请人:RETROVIROX INC
    公开号:WO2019213295A1
    公开(公告)日:2019-11-07
    The invention disclosed herein are embodiments of compounds capable of treating a viral infection. For example, the compounds are capable of inhibiting viral downmodulation of major histocompatibility complex I (MHC-I), such as by acting as immunomodulators of the immune system to treat, cure or eradicate a viral infection (e.g., HIV infection). More particularly, the present disclosure relates to the use of a heteroaryl compound or salts or analogs thereof, in the treatment of patients infected with a virus. The disclosed compounds may be used alone or in combination with other pharmacologically active agents to treat, cure or eradicate the virus, particularly in patients with persistent, latent viral infection. In some embodiments, the disclosed compounds can be used alone or in combination with other pharmacologically active agents to promote reactivation of viral production in latent cells and eradication of such cells.
    本公开的发明是能够治疗病毒感染的化合物的实施例。例如,这些化合物能够通过作为免疫调节剂来抑制病毒对主要组织相容性复合物I(MHC-I)的降调,从而治疗、治愈或根除病毒感染(例如HIV感染)。更具体地,本公开涉及在治疗感染病毒的患者中使用杂环芳基化合物或其盐或类似物。所公开的化合物可以单独使用或与其他药理活性剂联合使用,以治疗、治愈或根除病毒,特别是在患有持续潜伏病毒感染的患者中。在某些实施例中,所公开的化合物可以单独使用或与其他药理活性剂联合使用,促进潜伏细胞中病毒产生的重新激活和这些细胞的根除。
  • [EN] BETA-TETRAZOLYL-PROPIONIC ACIDS AS METALLO-BETA-LACTAMASE INHIBITORS<br/>[FR] ACIDES BÊTA-TÉTRAZOLYLE-PROPIONIQUES UTILES EN TANT QU'INHIBITEURS DES MÉTALLO-BÊTA-LACTAMASES
    申请人:MERCK SHARP & DOHME
    公开号:WO2015171474A1
    公开(公告)日:2015-11-12
    The present invention relates to compounds of formula I that are metallo-β-lactamase inhibitors, the synthesis of such compounds, and the use of such compounds for use with β-lactam antibiotics for overcoming resistance.
    本发明涉及公式I的化合物,这些化合物是金属β-内酰胺酶抑制剂,以及这些化合物的合成和与β-内酰胺类抗生素一起使用以克服抗性的用途。
查看更多

同类化合物

(1Z)-1-(3-乙基-5-羟基-2(3H)-苯并噻唑基)-2-丙酮 齐拉西酮砜 阳离子蓝NBLH 阳离子荧光黄4GL 锂2-(4-氨基苯基)-5-甲基-1,3-苯并噻唑-7-磺酸酯 铜酸盐(4-),[2-[2-[[2-[3-[[4-氯-6-[乙基[4-[[2-(硫代氧代)乙基]磺酰]苯基]氨基]-1,3,5-三嗪-2-基]氨基]-2-(羟基-kO)-5-硫代苯基]二氮烯基-kN2]苯基甲基]二氮烯基-kN1]-4-硫代苯酸根(6-)-kO]-,(1:4)氢,(SP-4-3)- 铜羟基氟化物 钾2-(4-氨基苯基)-5-甲基-1,3-苯并噻唑-7-磺酸酯 钠3-(2-{(Z)-[3-(3-磺酸丙基)-1,3-苯并噻唑-2(3H)-亚基]甲基}[1]苯并噻吩并[2,3-d][1,3]噻唑-3-鎓-3-基)-1-丙烷磺酸酯 邻氯苯骈噻唑酮 西贝奈迪 螺[3H-1,3-苯并噻唑-2,1'-环戊烷] 螺[3H-1,3-苯并噻唑-2,1'-环己烷] 葡萄属英A 草酸;N-[1-[4-(2-苯基乙基)哌嗪-1-基]丙-2-基]-2-丙-2-基氧基-1,3-苯并噻唑-6-胺 苯酰胺,N-2-苯并噻唑基-4-(苯基甲氧基)- 苯酚,3-[[2-(三苯代甲基)-2H-四唑-5-基]甲基]- 苯胺,N-(3-苯基-2(3H)-苯并噻唑亚基)- 苯碳杂氧杂脒,N-1,2-苯并异噻唑-3-基- 苯甲基2-甲基哌啶-1,2-二羧酸酯 苯并噻唑正离子,2-[3-(1,3-二氢-1,3,3-三甲基-2H-吲哚-2-亚基)-1-丙烯-1-基]-3-乙基-,碘化(1:1) 苯并噻唑正离子,2-[(2-乙氧基-2-羰基乙基)硫代]-3-甲基-,溴化 苯并噻唑啉 苯并噻唑-d4 苯并噻唑-6-腈 苯并噻唑-5-羧酸 苯并噻唑-5-硼酸频哪醇酯 苯并噻唑-4-醛 苯并噻唑-4-乙酸 苯并噻唑-2-磺酸钠 苯并噻唑-2-磺酸 苯并噻唑-2-磺酰氟 苯并噻唑-2-甲醛 苯并噻唑-2-甲酸 苯并噻唑-2-甲基甲胺 苯并噻唑-2-基磺酰氯 苯并噻唑-2-基叠氮化物 苯并噻唑-2-基-邻甲苯-胺 苯并噻唑-2-基-己基-胺 苯并噻唑-2-基-(4-氯-苯基)-胺 苯并噻唑-2-基-(4-氟-苯基)-胺 苯并噻唑-2-基-(4-乙氧基-苯基)-胺 苯并噻唑-2-基-(2-甲氧基-苯基)-胺 苯并噻唑-2-基-(2,6-二甲基-苯基)-胺 苯并噻唑-2-基(对甲苯基)甲醇 苯并噻唑-2-乙酸甲酯 苯并噻唑-2-乙腈 苯并噻唑-2(3H)-酮N2-[1-(吡啶-4-基)乙亚基]腙 苯并噻唑-2 - 丙基 苯并噻唑,6-(3-乙基-2-三氮烯基)-2-甲基-(8CI)